Gut 201463761-70. doi10.1136gutjnl-2013-304739.Lagier J-C Khelaifia S Alou MT Ndongo S Dione N Hugon P Caputo A Cadoret F Traore SI Seck EH Dubourg G Durand G Mourembou G Guilhot E Togo A Bellali S Bachar D Cassir N Bittar F Delerce J Mailhe M Ricaboni D Bilen M Dangui Nieko NP Dia Badiane NM Valles C Mouelhi D Diop K Million M Musso D Abrahao J Azhar EI Bibi F Yasir M Diallo A Sokhna C Djossou F Vitton V Robert C Rolain JM La Scola B Fournier PE Levasseur A Raoult D. Culture of previously uncultured members of the human gut microbiota by culturomics.

Cancer Prev Res Phila 201471112-21. doi10.11581940-6207.CAPR-14-0129.Ahn J Sinha R Pei Z Dominianni C Wu J Shi J Goedert JJ Hayes RB Yang L. Human gut microbiome and risk for colorectal cancer.

Casopis Lekaru Ceskych 20161557-12.Gagniere J Raisch J Veziant J Barnich N Bonnet R Buc E Bringer MA Pezet D Bonnet M. Gut microbiota imbalance and colorectal cancer.

and colorectal cancer cause or consequence Trends Microbiol 201321506-8. doi10.1016j.tim.2013.08.004.Dalmasso G Cougnoux A Delmas J Darfeuille-Michaud A Bonnet R. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment.

Clin Infect Dis 201153870-8. doi10.1093cidcir609.Corredoira-Sanchez J Garcia-Garrote F Rabunal R Lopez-Roses L Garcia-Pais MJ Castro E Gonzalez-Soler R Coira A Pita J Lopez- Alvarez MJ Alonso MP Varela J.

Int J Biochem Cell Biol 200133193-203.Donohoe DR Holley D Collins LB Montgomery SA Whitmore AC Hillhouse A Curry KP Renner SW Greenwalt A Ryan EP Godfrey V Heise MT Threadgill DS Han A Swenberg JA Threadgill DW Bultman SJ.

Clin Lab Med 201434699-710. doi10.1016j.cll.2014.08.002.Buc E Dubois D Sauvanet P Raisch J Delmas J Darfeuille-Michaud A Pezet D Bonnet R. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer.

Are we any closer to screening for colorectal cancer using microbial markersA critical reviewLubomir Starya Kristyna Mezerovab Pavel Skalickya Pavel Zborila Vladislav RaclavskybcThe role of gut microbiota in the development of sporadic colorectal cancer CRC is supported by a number of studies however the conclusiveness of published metagenomic studies is questioned by technical pitfalls and limited by small cohort sizes.

Last but not least we summarise available knowledge useful for improving care for patients immediately.Key words colorectal cancer microbiome culturomics screening markersReceived June 15 2017 Accepted November 15 2017 Available online December 13 2017 httpsdoi.org10.5507bp.2017.051aDepartment of Surgery I University Hospital Olomouc Czech RepublicbDepartment of Microbiology Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic cInstitute of Molecular and Translational Medicine Palacky University Olomouc Czech Republic Corresponding author Vladislav Raclavsky e-mail INTRODUCTIONSporadic colorectal cancer CRC represents 80-85 of all CRC cases.

J Gastroenterol 201550167-79. doi10.1007s00535-014-0963-x.Putze J Hennequin C Nougayrede J-P Zhang W Homburg S Karch H Bringer MA Fayolle C Carniel E Rabsch W Oelschlaeger TA Oswald E Forestier C Hacker J Dobrindt U.

